Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
暂无分享,去创建一个
R. Kreienberg | W. Eiermann | W. Jonat | F. Jänicke | M. Kaufmann | U. Kleeberg | J. Hilfrich | H. Schmid | M. Albrecht | H. Weitzel
[1] M. Kaufmann,et al. GnRH-Agonisten (Zoladex)-Therapie bei prämenopausalen Frauen mit metastasierendem Mammakarzinom* , 1988 .
[2] Jack Cuzick,et al. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women , 1988 .
[3] E. Kurschel,et al. Buserelin in the Treatment of Premenopausal Patients with Advanced Breast Cancer , 1988 .
[4] G. Burford,et al. Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women. , 1988, Fertility and sterility.
[5] A. Howell,et al. A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Williams,et al. The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer. , 1986, British Journal of Cancer.
[7] J. Ingle,et al. Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. Santen,et al. Treatment of breast cancer with gonadotropin-releasing hormone. , 1986, Endocrine reviews.
[9] J. Klijn,et al. LHRH-agonist treatment in clinical and experimental human breast cancer. , 1985, Journal of steroid biochemistry.
[10] A. Lipton,et al. Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Klijn. Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments , 1984, Medical oncology and tumor pharmacotherapy.
[12] A. Schally,et al. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms. , 1984, Cancer treatment reports.
[13] R. Nicholson,et al. Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancer. , 1982, Journal of reproduction and fertility.
[14] A. Corbin. From contraception to cancer: a review of the therapeutic applications of LHRH analogues as antitumor agents. , 1982, The Yale journal of biology and medicine.
[15] R. Rubens,et al. Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.
[16] R. Rubens,et al. Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.
[17] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[18] G. Beatson. On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases , 1896, Transactions. Medico-Chirurgical Society of Edinburgh.